Clinical Trial 40198

Garden Grove, CA 92845


Study Summary:

A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation


Qualified Participants Must:

• Men and women 18 through 65 years of age (inclusive) with a diagnosis of schizophrenia, who are experiencing an acute exacerbation or relapse of symptoms requiring hospitalization with onset less than 2 months prior to screening may be eligible for this study


Qualified Participants May Receive:

Compensation for time and gas 


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.